TherapeuticsMD (TXMD) Interest Expenses (2010 - 2025)

TherapeuticsMD (TXMD) has reported Interest Expenses for 12 consecutive years, with $3000.0 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Interest Expenses changed 0.0% year-over-year to $3000.0; the trailing twelve-month figure through Sep 2025 stood at $10000.0 (down 86.3% YoY), and the FY2021 full-year result was $32.9 million, up 15.17% from the prior year.
• Interest Expenses improved to $3000.0 in Q3 2025 per TXMD's latest filing, from $2000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $14.4 million in Q1 2022 and bottomed at $2000.0 in Q1 2025.
• Historically, Interest Expenses has averaged $3.7 million across 5 years, with a median of $45000.0 in 2023.
• The sharpest annual moves came in 2021 and 2023: Interest Expenses soared 63.32% in 2021, then plunged 99.65% in 2023.
• Over 5 years, Interest Expenses stood at $7.6 million in 2021, then surged by 90.23% to $14.4 million in 2022, then plunged by 99.86% to $20000.0 in 2023, then slumped by 85.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
• According to Business Quant data, Interest Expenses over the past three periods registered $3000.0, $2000.0, and $2000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.